This should include a comprehensive analysis of pharmaceutical agents used to regulate ventricular rate in atrial fibrillation, such as beta blockers, calcium channel blockers, digoxin, amiodarone, and ACE inhibitors, as these have been shown to reduce the risk of post-stroke aspiration pneumonia. The gene discussed is ACE; the disease is atrial fibrillation.